IP Library Granted Patent US 10,780,276
Granted Patent B1
US 10,780,276 · App. 15/938,408 · Granted Sep 22, 2020

Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator

Inventor: Kerry Bradley (Glendale, CA)
Assignee: Nevro Corp.
A61N1/36071A61N1/36132A61N1/36171A61N1/3787A61N1/37247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,780,276
App. No.
15/938,408
Granted
Sep 22, 2020
Kind
B1
Abstract

Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator are disclosed. A representative system includes a signal generator and a computer-readable medium that, for first and second signals, increases and decreases an amplitude of the signal over multiple steps from a baseline amplitude at which the patient has a baseline response. At individual step increases and decreases, the system receives a pain score based on the patient's response. The instructions compare the pain scores for the two signals and determine one of the signals for additional therapy to the patient, based on the pain scores and an expected energy consumption of the signals.

Claims (47)

1. A neurological stimulation system, comprising:

a signal generator coupleable to a signal delivery device to deliver a first therapy signal to a patient at a first frequency and a second therapy signal to the patient at a second frequency different than the first frequency; and

one or more non-transitory computer readable media programmed with instructions that, when executed:

for both the first and second therapy signals,

(i) change a signal parameter of the signal, over multiple steps, from a baseline value at which the patient has a baseline response, wherein the signal parameter includes at least one of a signal amplitude, a signal pulse width, or a signal duty cycle, and wherein at least one of the first therapy signal or the second therapy signal does not induce paresthesia in the patient over the multiple steps; and

(ii) for individual step changes, receive an efficacy measure based on the patient's response to the changed value; and

after changing the signal parameter and receiving the efficacy measures, direct one of the first and second therapy signals to the patient.

2. The method of claim 1 wherein the efficacy measure includes a pain score.

3. The system of claim 1 wherein the signal generator is an implantable signal generator.

4. The system of claim 3 wherein the one or more computer readable media is carried by the implantable signal generator.

5. The system of claim 3 wherein a first portion of the one or more computer readable media is carried by the implantable signal generator and a second portion of the one or more computer-readable media is carried off the implantable signal generator.

6. The system of claim 3 wherein a first portion of the instructions are executed by the implantable signal generator and a second portion of the instructions are carried out by a patient remote.

7. The system of claim 1 wherein the signal parameter is a signal amplitude and wherein an incremental value for changing the amplitude is 0.1 mA.

8. The system of claim 1 wherein the first frequency is higher than the second frequency.

9. The system of claim 1 wherein the first and second frequencies are both at least 1.5 kHz.

10. The system of claim 1 wherein the first frequency is from 10 kHz to 100 kHz, inclusive and the second frequency is from 1.5 kHz to 10 kHz.

11. The system of claim 1 wherein the instructions, when executed, determine the expected energy consumption for the first and second therapy signals.

12. The system of claim 1 wherein the instructions, when executed, select one of the first and second therapy signals for additional therapy based at least in part on a patient preference for at least one of a pain reduction level or a charging interval.

13. A neurological stimulation system, comprising:

a signal generator coupleable to a signal delivery device to deliver a first therapy signal to a patient at a first frequency and a second therapy signal to the patient at a second frequency different than the first frequency; and

one or more non-transitory computer readable media programmed with instructions that, when executed:

for both the first and second therapy signals,

(i) change a signal parameter of the signal, over multiple steps, from a baseline value at which the patient has a baseline response, wherein the signal parameter includes at least one of a signal amplitude, a signal pulse width, or a signal duty cycle, and wherein at least one of the first therapy signal or the second therapy signal is delivered at individual steps of the multiple steps for a predetermined time, and wherein at least one of the first therapy signal or the second therapy signal does not induce paresthesia in the patient over the multiple steps; and

(ii) for individual step changes, receive an efficacy measure based on the patient's response to the changed value; and

after changing the signal parameter and receiving the efficacy measures, direct one of the first and second therapy signals to the patient.

14. The system of claim 13 wherein the predetermined time is at least 12 hours.

15. The system of claim 13 wherein the predetermined time is at least 24 hours.

16. A neurological stimulation system, comprising:

a signal generator coupleable to a signal delivery device to deliver a first therapy signals and a second therapy signal to a patient to reduce pain in the patient, the first therapy signal being delivered at a first frequency and the second therapy signal being delivered at a second frequency different than the first frequency; and

one or more non-transitory computer readable media programmed with instructions that, when executed:

for both the first and second therapy signals,

(i) automatically change a signal parameter of the signal, over multiple steps, from a baseline value at which the patient has a baseline response, wherein the signal parameter includes at least one of a signal amplitude, a signal pulse width, or a signal duty cycle, and wherein at least one of the first therapy signal or the second therapy signal does not induce paresthesia in the patient over the multiple steps; and

(ii) for individual step changes, receive an efficacy measure based on the patient's response to the changed value; and

after changing the signal parameter and receiving the efficacy measures, direct one of the first and second therapy signals to the patient.

17. The system of claim 16 wherein the signal parameter is a signal amplitude.

18. The system of claim 16 wherein the first therapy signal and the second therapy signal do not induce paresthesia in the patient over the multiple steps.

19. A neurological stimulation system, comprising:

a signal generator coupleable to a signal delivery device to deliver a first therapy signal to a patient at a first frequency of at least 1.5 k Hz and a second therapy signal to the patient at a second frequency different than the first frequency; and

one or more non-transitory computer readable media programmed with instructions that, when executed:

for both the first and second therapy signals,

(i) change a signal parameter of the signal, over multiple steps, from a baseline value at which the patient has a baseline response, wherein the signal parameter includes at least one of a signal amplitude, a signal pulse width, or a signal duty cycle, and wherein at least one of the first therapy signal or the second therapy signal does not induce paresthesia in the patient over the multiple steps; and

(ii) for individual step changes, receive an efficacy measure based on the patient's response to the changed value, the efficacy measure including a pain score; and

after changing the signal parameter and receiving the efficacy measures, direct one of the first and second therapy signals to the patient.

20. The system of claim 19 wherein the first and second frequencies are both at least 1.5 kHz.

21. The system of claim 19 wherein the first frequency is from 10 kHz to 100 kHz, inclusive, and the second frequency is from 1.5 kHz to 10 kHz.

22. The system of claim 19 wherein the first therapy signal does not induce paresthesia in the patient over the multiple steps.

23. The system of claim 19 wherein the first therapy signal and the second therapy signal do not induce paresthesia in the patient over the multiple steps.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2023
From: BRADLEY, KERRY
To: NEVRO CORP.
Reel/Frame 062802/0297 →
Continuity (3)
Continuation 15346432 · Nov 8, 2016
Continuation 15057913 · Mar 1, 2016
Continuation 14657971 · Mar 13, 2015